Artelo Biosciences, Inc. (ARTL)
3.11
0.00 (0.00%)
USD |
NASDAQ |
Oct 13, 09:43
Artelo Biosciences Net Income (Quarterly) : -2.427M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.427M |
| March 31, 2026 | -2.958M |
| December 31, 2025 | -4.166M |
| September 30, 2025 | -3.12M |
| June 30, 2025 | -3.221M |
| March 31, 2025 | -2.372M |
| December 31, 2024 | -3.778M |
| September 30, 2024 | -1.132M |
| June 30, 2024 | -2.433M |
| March 31, 2024 | -2.483M |
| December 31, 2023 | -3.073M |
| September 30, 2023 | -2.449M |
| June 30, 2023 | -1.599M |
| March 31, 2023 | -2.168M |
| December 31, 2022 | -3.339M |
| September 30, 2022 | -2.33M |
| June 30, 2022 | -2.449M |
| March 31, 2022 | -1.965M |
| August 31, 2021 | -1.887M |
| Date | Value |
|---|---|
| May 31, 2021 | -2.250M |
| February 28, 2021 | -1.866M |
| November 30, 2020 | -1.435M |
| August 31, 2020 | -1.027M |
| May 31, 2020 | -0.9512M |
| February 29, 2020 | -1.370M |
| November 30, 2019 | -1.306M |
| August 31, 2019 | -0.8456M |
| May 31, 2019 | -0.3449M |
| February 28, 2019 | -0.4248M |
| November 30, 2018 | -0.5569M |
| August 31, 2018 | -0.6901M |
| May 31, 2018 | -0.5779M |
| February 28, 2018 | -0.6284M |
| November 30, 2017 | -0.2771M |
| August 31, 2017 | -0.1157M |
| May 31, 2017 | -0.0966M |
| February 28, 2017 | -0.013M |
| November 30, 2016 | -0.0095M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 5.534B |
| Eli Lilly & Co. | 7.095B |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 2.427M |
| EPS Diluted (Quarterly) | -0.8949 |
| Enterprise Value | 8.877M |
| Earnings Yield | -739.0% |
| Normalized Earnings Yield | -697.99 |